Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 167Breast 134Gynecologic 113Thoracic 99Head & Neck 35Genitourinary 24Dermatologic 18Other solid neoplasm 14Tumor-Agnostic 12Sarcoma 11Lymphoid 4CNS 4Other neoplasm 3Other hematologic neoplasm 3Endocrine 3Plasma cell 2Classical hematology 2Other 1Myeloid 1

Conditions

Obesity 1Neurotoxicity Syndromes 1Fatigue 1

Interventions

Exercise 27Metformin 24Methods 14Radiotherapy 13Early Intervention, Educational 13Educational Status 12Counseling 12Surveys and Questionnaires 10Standard of Care 10Nutrition Assessment 9Resistance Training 8Diet Therapy 8Cisplatin 8naloxegol 7Tirzepatide 7Diet 7alvimopan 6Psychiatric Rehabilitation 6Fibroblast Growth Factor 7 6Caloric Restriction 6Radiation 5Low-Level Light Therapy 5Liraglutide 5Injections 5Exenatide 5Dexamethasone 5Cryotherapy 5semaglutide 4angiotensin I (1-7) 4Vitamin D 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Taxes × Other × Clear all
NCT00807768 2019-03-20

Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer

GOG Foundation

Phase 3 Unknown
601 enrolled 13 charts
Other

Fatigue, Obesity, Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡